the present invention relates to the delivery of anti - migraine compounds through an inhalation route . specifically , it relates to aerosols containing lidocaine , verapamil , diltiazem , isometheptene , or lisuride that are used in inhalation therapy . in a method aspect of the present invention , lidocaine , verapamil , diltiazem , isometheptene , or lisuride is administered to a patient through an inhalation route . the method comprises : a ) heating a composition of lidocaine , verapamil , diltiazem , isometheptene , or lisuride , to form a vapor ; and , b ) allowing the vapor to cool , thereby forming a condensation aerosol comprising particles with less than 5 % drug degradation products . in a kit aspect of the present invention , a kit for delivering lidocaine , verapamil , diltiazem , isometheptene , or lisuride through an inhalation route is provided which comprises : a ) a thin coating of a lidocaine , verapamil , diltiazem , isometheptene , or lisuride composition and b ) a device for dispensing said thin coating as a condensation aerosol .